OptiBiotix Health Share Forecast, Price & News

GBX 47
0.00 (0.00 %)
(As of 07/29/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume235,973 shs
Average Volume357,549 shs
Market Capitalization£41.33 million
P/E Ratio7.70
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive OPTI News and Ratings via Email

Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter.

OptiBiotix Health logo

About OptiBiotix Health

Optibiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that ID used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; and Sweetbiotix, a sweetener for use in food products and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. Optibiotix Health Plc has an agreement with Fondazione Edmund Mach - Centro Ricerca e Innovazione to jointly fund and carry out a research project examining the role of its microbiome products to improve sleep, stress, and anxiety. The company was founded in 2012 and is headquartered in York, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

OptiBiotix Health (LON:OPTI) Frequently Asked Questions

What stocks does MarketBeat like better than OptiBiotix Health?

Wall Street analysts have given OptiBiotix Health a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but OptiBiotix Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is OptiBiotix Health's next earnings date?

OptiBiotix Health is scheduled to release its next quarterly earnings announcement on Wednesday, September 22nd 2021.
View our earnings forecast for OptiBiotix Health

How were OptiBiotix Health's earnings last quarter?

OptiBiotix Health Plc (LON:OPTI) announced its earnings results on Thursday, September, 24th. The company reported ($0.70) earnings per share (EPS) for the quarter.
View OptiBiotix Health's earnings history

How has OptiBiotix Health's stock been impacted by Coronavirus (COVID-19)?

OptiBiotix Health's stock was trading at GBX 42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OPTI stock has increased by 11.9% and is now trading at GBX 47.
View which stocks have been most impacted by COVID-19

Who are OptiBiotix Health's key executives?

OptiBiotix Health's management team includes the following people:
  • Mr. Stephen Patrick O'Hara, Founder, CEO & Exec. Director
  • Dr. Sofia Kolyda, Director of R&D and Exec. Director (Age 47, Pay $98.45k)
  • Mr. Mark Kingsley Collingbourne, Chief Financial Officer (Age 55)
  • Ms. Aneta Zlotkowska, Head of Quality & Operations
  • Kevin James Newman, Corp. Devel. Director
  • Mr. Steven Riley, Head of Consumer Health division
  • Mr. Rene Kamminga, CEO of Functional Fibres & Director

Who are some of OptiBiotix Health's key competitors?

What other stocks do shareholders of OptiBiotix Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OptiBiotix Health investors own include (DGS.L) (DGS), Derwent London (DLN), Oracle (ORCL), IQE (IQE), IP Group (IPO), London Stock Exchange Group plc (LSE.L) (LSE), Petrofac (PFC), Motif Bio (MTFB), Yamana Gold (YRI) and Agios Pharmaceuticals (AGIO).

What is OptiBiotix Health's stock symbol?

OptiBiotix Health trades on the London Stock Exchange (LON) under the ticker symbol "OPTI."

How do I buy shares of OptiBiotix Health?

Shares of OPTI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is OptiBiotix Health's stock price today?

One share of OPTI stock can currently be purchased for approximately GBX 47.

How much money does OptiBiotix Health make?

OptiBiotix Health has a market capitalization of £41.33 million and generates £1.52 million in revenue each year.

How many employees does OptiBiotix Health have?

OptiBiotix Health employs 10 workers across the globe.

What is OptiBiotix Health's official website?

The official website for OptiBiotix Health is www.optibiotix.com.

Where are OptiBiotix Health's headquarters?

OptiBiotix Health is headquartered at Innovation Centre, Innovation Way, HESLINGTON, YO10 5DG, United Kingdom.

How can I contact OptiBiotix Health?

OptiBiotix Health's mailing address is Innovation Centre, Innovation Way, HESLINGTON, YO10 5DG, United Kingdom. The company can be reached via phone at +44-20-79338780.

This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.